CellCura ASA (Oslo Axess: CELL) will present the report for Q1, 2014 on Friday 30 May 2014 at 9 pm. The presentation will be held in the company's office at Vika Atrium, Munkedamsveien 45 A, 5th floor, Oslo.

CEO Tore Viana-Rønningen will represent the company. The report and presentation will be published through Newsweb and on CellCura's webpage before the presentation.

We invite investors, analysts and media to attend the presentation. Please give notice of participation by e-mail to tvr@cellcura.com or telephone +47 22 94 77 00.

For further information, please contact CEO Tore Viana-Rønningen.

Oslo, 14 May 2014

CellCura ASA

Tore Viana-Rønningen
Chief Executive Officer
Telefon: +47 911 08 693

CellCura ASA is dedicated to the development and sales of cell technologies for use in assisted reproductive technology (ART) and stem cell research worldwide, representing improved safety and efficiency compared to traditional technology. CellCura is listed on the Oslo Axess market at the Oslo Stock Exchange (ticker: CELL).

www.cellcura.com

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)

distributed by